Australian (ASX) Stock Market Forum

PER - Percheron Therapeutics

Jump to new
ANP is my pick for the November tipping comp.
They possibly have the most promising treatment for Duchennes Muscular Dystrophy, a truly horrific disease for which there is currently no effective therapy. ANP has conducted a successful Phase 2 trial.
In the pipeline ANP has other products to tackle MS, Acromegaly and cancer.
A cap raise has stalled the rise that positive news for Europe was about to bring.
 
ANP is one of my picks in the 2022 tipping comp. Exciting new(ish) technology that provides hope for a wide range of diseases using genetic manipulation. Many of the diseases they are working on currently have little or no effective treatments. If they succeed in just one their MC will be many multiples of where it is now.
 
This could go in the potential breakout thread, or here.

Screenshot_20220901-154427.png
 
On January 4th, 2024, Antisense Therapeutics Limited (ANP) changed its name and ASX code to Percheron Therapeutics Limited (PER).
 
Percheron is my March Competition selection, this company is fully funded through to various end stage trials due in the second half of 2024. It is important to note their board is packed with experienced members able to steer the good work of researchers in this worthwhile cause with the hope will help trial participants and ultimately shareholders.
 
Top